Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VELIPARIB vs VERTEPORFIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VELIPARIB vs VERTEPORFIN: Safety Overview

Metric VELIPARIB VERTEPORFIN
Total FAERS Reports 391 753
Deaths Reported 43 19
Death Rate 11.0% 2.5%
Hospitalizations 222 46
Average Patient Age 57.9 yrs 68.4 yrs
% Female Patients 92.3% 31.1%
FDA Approval Date N/A Apr 12, 2000
Manufacturer N/A Bausch Health US LLC
Route N/A INTRAVENOUS
Marketing Status N/A Prescription